This month, we sat down with Dr. Brinton Seashore-Ludlow. Dr. Seashore-Ludlow has a PhD in organic chemistry and synthetic methods from The Royal Institute of Technology (KTH) in Stockholm and did a postdoc at the Broad Institute of Harvard and MIT. Currently, she is a Senior Researcher at Karolinska Institutet and the Chemical Biology Consortium of Sweden focusing on precision cancer medicine.
This month, we sat down with Dr. Elvira Weber, adipose tissue organoid pioneer, expert in regenerative medicine, and Head of Lab at the CURE 3D lab in Düsseldorf.
This month, we sat down with Dr. Maryna Panamarova, a technical expert in the 3D culture space. Dr. Panamarova is working to develop and upscale novel organoid models at the Wellcome Sanger Institute. She is an advocate for making knowledge open source and believes it’s key to advancing the industry forward.
This month, we sat down with Dr. Tamara Zietek, a pioneer in 3D intestinal modelling and a leading voice pushing for the replacement of animal testing in life science with New Approach Methodologies (NAMs). We discuss her journey, the evolution of in-vitro 3D models, regulatory hurdles, and how we can achieve a paradigm shift in drug development.
In the realm of 3D cell culture, the diversity of terminology – from organoids and tumoroids to spheroids and Microphysiological Systems (MPS) – reflects innovation but also creates barriers to communication and adoption.